Filter
360
Text search:
Leishmaniasis
Featured
Recommendations
42
New Publications
79
Language
Document type
No document type
141
Studies & Reports
78
Guidelines
44
Strategic & Response Plan
25
Manuals
18
Videos
16
Resource Platforms
14
Fact sheets
11
Situation Updates
4
Infographics
4
Training Material
3
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
51
Latin America and the Carribbean
17
Ethiopia
16
India
13
Paraguay
11
Colombia
10
Africa
10
Nepal
9
Kenya
8
Bangladesh
8
Syria
7
Uganda
6
Middle East and North Africa
6
Sudan
5
Brazil
5
Western and Central Europe
5
Venezuela
5
Bolivia
4
Congo, Democratic Republic of
3
Ghana
3
Somalia
3
South Sudan
3
Iraq
3
Jordan
3
Lebanon
3
Zambia
3
East and Southern Africa
3
Nigeria
2
Saudi Arabia
2
Pakistan
2
Turkey
2
Malawi
2
Peru
2
Ecuador
2
South–East Asia Region
2
Eastern Europe
2
Iran
2
Sierra Leone
1
Liberia
1
Morocco
1
Cameroon
1
Togo
1
Afghanistan
1
Germany
1
Egypt
1
Chad
1
Tanzania
1
Cambodia
1
China
1
Rwanda
1
Indonesia
1
South Africa
1
North Macedonia
1
Honduras
1
Greece
1
Libya
1
Angola
1
Mexico
1
Myanmar / Burma
1
Yemen
1
West and Central Africa
1
Asia
1
Palestine
1
Albania
1
Djibouti
1
Qatar
1
Georgia
1
North America
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
114
Clinical Guidelines
61
Public Health
33
Key Resources
14
Capacity Building
5
Pharmacy & Technologies
5
Women & Child Health
4
Toolboxes
NTDs
128
Planetary Health
23
HIV
14
Rapid Response
11
Global Health Education
8
Conflict
7
Refugee
7
COVID-19
6
TB
4
Caregiver
4
Pharmacy
3
NCDs
3
Natural Hazards
2
Zika
2
Disability
1
Ebola
1
Cholera
1
Polio
1
AMR
1
Health Financing Toolbox
1
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Ciudad de Panamá, Panamá 2 y 3 de marzo, 2010
Transforming Health: Accelerating attainment of Health Goals | THE SECOND MEDIUM TERM PLAN FOR HEALTH
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te
...
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical staff involved in the eradication of yaws.
The strategic plan reflects shared commitments to enhance collaboration between environmental, animal (wildlife and domestic) and human health, and building new One Health workforce capacity through higher institutions of learning. The strategy also outlines interventions to be undertaken by governm
...
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio ...
In May 2017, the World Health Assembly adopted resolutio ...
